Medical School News and Research

RSS

Intercellular communication pathway drives motivation to seek cocaine

In the October 28, 2020 issue of the Journal of Neuroscience, researchers from the Medical University of South Carolina and the National Institutes of Health describe how reminders of drug use can change specific brain cells responsible for motivation, increasing the desire to seek drugs.

29 Oct 2020

Remdesivir received FDA approval for treating COVID-19 patients: Benefits still not proven

The United States has become the epicenter of the world in the ever increasing pandemic of COVID-19. While public health prevention strategies of social distancing, crowd avoidance, masking and frequent hand washing are of proven benefit, effective drug therapies for treatment are sparse.

29 Oct 2020

Some COVID-19 patients continue to have persistent skin-related symptoms, shows study

Some patients with COVID-19 have persistent skin-related symptoms long after their initial infection has cleared, according to a new analysis.

29 Oct 2020

Majority of people infected with mild-to-moderate COVID 19 mount robust antibody response

The vast majority of individuals infected with mild-to-moderate COVID 19 mount a robust antibody response that is relatively stable for at least five months, according to research conducted at the Icahn School of Medicine at Mount Sinai and published October 28, in the journal Science.

29 Oct 2020

McLean Hospital joins public-private partnership to find cure for schizophrenia

In September, McLean Hospital joined the National Institutes of Health, the U.S. Food and Drug Administration, and several public and private organizations to find early therapeutic interventions for people at risk for schizophrenia.

29 Oct 2020

New report offers guidance on cardiac screening of athletes infected with COVID-19

Reports have indicated that COVID-19 may cause heart damage in hospitalized patients with severe cases of the disease, but it's unclear whether cardiac injury also occurs in infected patients who are asymptomatic or experience only mild symptoms.

29 Oct 2020

New portable arm rehabilitation device launched to help patients perform robot-aided therapy at home

A new portable arm rehabilitation robot will help patients to carry out robot-aided therapy at home, allowing them to perform intensive exercises without visiting hospitals or clinics, which can possibly reduce the risk of exposure to infectious diseases such as COVID-19.

28 Oct 2020

Grant programs will provide $2.2 million to support biomedical research on healthy aging

The Glenn Foundation for Medical Research and the American Federation for Aging Research announce the 2020 recipients of three grant programs: the Glenn Foundation for Medical Research and AFAR Grants for Junior Faculty, the Glenn Foundation for Medical Research Postdoctoral Fellowships in Aging Research, and the Glenn Foundation for Medical Research Breakthroughs in Gerontology Awards.

28 Oct 2020

Researchers investigate why people with dementia go missing

People with dementia are more likely to go missing in areas where road networks are dense, complicated and disordered – according to new research from the University of East Anglia.

28 Oct 2020

Scientists receive $3.9 million to optimize treatment for opioid use disorder

Drawing upon their experience and expertise in telehealth, collaborative care models, substance use disorders, depression and health information technology, Indiana University School of Medicine and Regenstrief Institute faculty have been awarded $3.9 million over four years to collaborate with Kaiser Permanente Washington Health Research Institute scientists on a trial to optimize treatment for opioid use disorder.

28 Oct 2020

Scripps Research professor receives prestigious award for advocacy efforts

Courtney Miller, PhD, an associate professor in the departments of Molecular Medicine and Neuroscience at Scripps Research, has been awarded the Louise Hanson Marshall Special Recognition Award from the Society for Neuroscience for her efforts promoting women in science.

28 Oct 2020

Study: Four in 10 people with advanced multiple sclerosis are emotionally abused by caregivers

Four in 10 people with advanced multiple sclerosis, or MS, are emotionally abused by someone responsible for caring for them, reports a study led by the University of California, Riverside.

28 Oct 2020

Furin cleavage site and D614G on SARS-CoV-2 spike evolved to balance infectivity, stability, cytopathicity

SARS-CoV-2 is the causative agent of COVID-19 disease, currently raging across the world. The virus has now infected more than 43.89 million individuals and claimed over 1.16 million lives. The study titled, "Spike glycoprotein and host cell determinants of SARS-CoV-2 entry and cytopathic effects," is released on the preprint server bioRxiv* in October 2020.

27 Oct 2020

Medical School News and Research

Intercellular communication pathway drives motivation to seek cocaine

Remdesivir received FDA approval for treating COVID-19 patients: Benefits still not proven

Some COVID-19 patients continue to have persistent skin-related symptoms, shows study

Majority of people infected with mild-to-moderate COVID 19 mount robust antibody response

McLean Hospital joins public-private partnership to find cure for schizophrenia

New report offers guidance on cardiac screening of athletes infected with COVID-19

New portable arm rehabilitation device launched to help patients perform robot-aided therapy at home

Grant programs will provide $2.2 million to support biomedical research on healthy aging

Researchers investigate why people with dementia go missing

Scientists receive $3.9 million to optimize treatment for opioid use disorder

Scripps Research professor receives prestigious award for advocacy efforts

Study: Four in 10 people with advanced multiple sclerosis are emotionally abused by caregivers

Furin cleavage site and D614G on SARS-CoV-2 spike evolved to balance infectivity, stability, cytopathicity

Advancements in research on cancer signal transduction and treatment

Study finds a significant drop in death rates among people with severe COVID-19 in England

Telemedicine or in-person visit? Pros and cons

Impact of natural and vaccine-induced immunity could shape the future trajectory of COVID-19

Expression of a specific gene could regulate feelings of fear and its extinction

Study identifies cardiac structural damage experienced by COVID-19 patients

New tool predicts prognosis of individual patients with COVID-19

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News